Sitamon Tablets 25 mg (Sitagliptin Hydrochloride Hydrate)

Adult dosage

This medication is administered once daily at a dose of 100 mg, either as monotherapy or combination therapy, with a maximum daily dose of 100 mg. For patients with renal impairment, a dose of 50 mg is administered once daily for moderate renal impairment (glomerular filtration rate [eGFR] 30–45 mL/min/1.73 m2). For severe renal impairment (glomerular filtration rate [eGFR] 15–30 mL/min/1.73 m2) or end-stage renal disease (glomerular filtration rate [eGFR] <

This medication may cause serious allergic reactions in some patients, so if any symptoms such as skin rash, difficulty breathing, or swelling of the face or lips occur after taking the medication, it should be stopped immediately and medical advice should be sought. During treatment with this medication, pancreatitis may occur, so if symptoms such as abdominal pain, vomiting, or loss of appetite appear, the doctor should be informed immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and it should also be avoided if there is an allergy to this medication or its components. Patients with reduced kidney function need dosage adjustment, so regular kidney function tests should be conducted and the medication should be taken under medical supervision. In clinical trials, patients taking this medication reported side effects such as nasopharyngitis, headache, and upper respiratory infections compared to placebo, and particularly when used with insulin or sulfonylureas, the risk of hypoglycemia may increase. When used with other hypoglycemic agents, there is a risk of hypoglycemia, so patients should be cognizant of hypoglycemic symptoms and should check their blood sugar levels frequently as needed. If serious joint pain or skin blisters appear, the use of this medication should be discontinued and medical personnel should be informed immediately. Pregnant or breastfeeding women are advised to avoid using this medication, and safety and efficacy have not been established in children and adolescents under the age of 18. In elderly patients, kidney function may decline, so kidney function should be assessed prior to use and the dosage adjusted accordingly. In case of overdose, general symptomatic treatment is provided, and blood dialysis may be performed to remove some of the medication as necessary.

Serious side effects

• Hives
• angioedema
• chest tightness
• difficulty breathing
• cold sweat
• paleness
• anaphylaxis
• severe swelling
• severe allergic reactions
• severe rash

Mild side effects

• Upper respiratory infections
• nasopharyngitis
• headache
• diarrhea
• nausea
• abdominal pain
• constipation
• vomiting
• muscle pain
• limb pain

This medication should be stored in a closed container to prevent exposure to air and moisture, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication over time.

Appearance

Pink, round, biconvex, film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP * 2]